The Structural Basis of TAM Receptor Oligomerizarion and Co-receptor Interactions
The Structural Basis of TAM Receptor Oligomerizarion and Co-receptor Interactions
批准号:
10759499
负责人:
Chrystal Starbird
金额:
$24.9万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-02-15 至 2026-01-31
关键词:
AdultAffectApoptoticAutoimmune DiseasesBindingBiochemicalBiochemistryBiological ProcessBiophysicsCancer BiologyCardiovascular DiseasesCell Surface ReceptorsCell SurvivalCell membraneCellsChronicClinicalComplexCytokine ReceptorsDataDevelopmentDimerizationDiseaseEnvironmentEpidermal Growth Factor ReceptorExtracellular DomainFamilyFibronectinsHomeostasisImmune responseImmune systemInfertilityInflammationInflammatory ResponseInvestigationKineticsLaboratoriesLengthLigand BindingLigandsLinkMaintenanceMalignant NeoplasmsMediatingMembraneMentorsMentorshipMicroscopyModelingMolecularMolecular ConformationNaturePhosphorylationPhosphotransferasesPlayProcessProliferatingReceptor ActivationReceptor Protein-Tyrosine KinasesReceptor SignalingRegulationResearchResourcesRoleSignal PathwaySignal TransductionStructureTechniquesTestingTherapeuticTissuesTrainingVascular SystemVirusVirus DiseasesWorkbiophysical analysisbiophysical techniquescareer developmentcell motilitydimerequity, diversity, and inclusionextracellularhereditary blindnessimprovedinnovationinsightinterestnovel therapeuticsprogramsreceptorreceptor-mediated signalingresponseskillstargeted treatmenttheoriestherapeutic target
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT
TAM receptors are a clinically important and mechanistically under-studied RTK subfamily. These receptors have
a vital role in maintaining cellular homeostasis through the clearance of apoptotic cells and control of
inflammatory and immune responses. Linked to their important regulatory roles, dysregulation of TAM
receptors is implicated in numerous disease states including cardiovascular disease, hereditary blindness,
infertility, autoimmune disorders, chronic inflammation and cancer. In addition, TAM receptor mediated
signaling pathways can be hijacked by viruses to gain entry into host cells. While there is growing interest in
TAM receptors as therapeutic targets, their multiple roles in homeostatic processes create challenges for
developing therapeutic strategies. Understanding TAM receptor activation mechanisms is important for further
investigation of the potential development of targeted therapies. While these receptors are commonly believed
to be activated through classical receptor-induced dimerization, my preliminary work presents the first in-depth
study of the biochemistry and suggests that this simplified view may not be applicable to TAM receptors.
Importantly, to fully understand how TAMs are activated, I intend to utilize a combination of structural,
biophysical and biochemical approaches to investigate TAM oligomerization and cross-talk with other receptors.
These studies will guide the development of informed theories of TAM receptor activation and provide
important insights that may be used for the development of new therapeutics in cancer and viral and
autoimmune diseases. The laboratory of Dr. Kathryn Ferguson at the Yale Cancer Biology Institute provides a
supportive and innovative research environment to conduct this research, as well as mentorship that is aimed
at improving skills necessary for a transition to independence. With access to a wealth of resources and to
leading experts in the approaches proposed in this application, I will gain additional training in advanced
microscopy techniques to augment my previous and ongoing training. The combination of specialized training
in additional structural and biophysical approaches, mentorship and career development activities led by my
mentors and at Yale, participation in UE5 activities and my continued work with the Office of Diversity, Equity
and Inclusion at Yale, will prepare me to lead a strong independent research program.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Structural Basis of TAM Receptor Oligomerizarion and Co-receptor Interactions
-
批准号:10349217
-
项目类别:
-
资助金额:$9.67万
-
财政年份:2022
-
负责人:Chrystal Starbird
-
依托单位:
Effects of phosphatidylserine and oligomerization on activation mechanisms of TAM receptors
-
批准号:10084164
-
项目类别:
-
资助金额:$6.86万
-
财政年份:2020
-
负责人:Chrystal Starbird
-
依托单位:
海外基金